Microbix Biosystems Inc.

All right, I think we can get started. Good morning, everyone. Thanks for joining us. We have an update from Microbics to discuss their fiscal Q1 2026 results. Sequential improvement quarter over quarter, so starting to see a rebound in company progress after 2025, which we all know is A bit of a down year due to two events outside the company's control, but things seem to be tracking in the right direction. So here to tell us more about that, I have Cameron Groom, CEO, Jim Curry, CFO, Ken Hughes, COO. We won't be working off a presentation today. We will be finalizing the presentation with the Q1 numbers, so you can expect to see that online either later today or tomorrow at the latest. And we will have a Q&A section, so feel free to enter questions in the Q&A box. And, again, not working off a presentation, but we are going to talk about forward-looking statements. So if you'd like to know more about those, you can find them on the presentation on the company's website. With that all out of the way, I'll hand the mic over to Cameron, who I think is going to give us a little bit of a review on the quarter.

Thank you. Good morning, Debra. Thank you, Debra and everyone. Debra, you didn't want to spend five or ten minutes reading through a detailed safe harbor statement?

Oh, yeah, I would love to. Should I pull it up?